Which inflammatory markers should be ordered to evaluate acute inflammation or infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Inflammatory Markers for Acute Inflammation or Infection

Order C-reactive protein (CRP) and procalcitonin (PCT) as your primary inflammatory markers to evaluate acute inflammation or infection, with PCT having superior diagnostic accuracy for bacterial sepsis. 1

Primary Markers to Order

Procalcitonin (PCT)

  • PCT is the preferred biomarker for bacterial infection discrimination with higher diagnostic accuracy than CRP 1
  • Diagnostic performance for sepsis:
    • Sensitivity: 80% (95% CI, 0.69–0.87)
    • Specificity: 77% (95% CI, 0.60–0.88)
    • Area under ROC curve: 0.85 (95% CI, 0.82–0.88)
    • Diagnostic odds ratio: 12.50 1
  • Rises within 4 hours of bacterial exposure, peaks at 6-8 hours 1
  • Normal value: <0.05 ng/mL 1
  • Results available within 1 hour with point-of-care testing 1

Important caveat: PCT may be elevated in severe viral illness including influenza and COVID-19, reducing its discriminating power for bacterial vs. viral etiology 1

C-Reactive Protein (CRP)

  • CRP is the alternative first-line marker when PCT is unavailable or cost-prohibitive 1
  • Diagnostic performance for sepsis:
    • Sensitivity: 80% (95% CI, 0.63–0.90)
    • Specificity: 61% (95% CI, 0.50–0.72)
    • Area under ROC curve: 0.73 (95% CI, 0.69–0.77)
    • Diagnostic odds ratio: 6.89 1
  • Rises 12-24 hours after inflammatory insult, peaks at 48 hours 1
  • Normal value: <5 mg/L; typical cutoff: 10 mg/L 1
  • Limitations: Affected by neutropenia, immunodeficiency, and NSAID use 1

Secondary Markers (Context-Dependent)

Complete Blood Count with Differential

  • Provides absolute neutrophil count (ANC), which has 75.4% accuracy for predicting infection 2
  • Neutrophil-to-lymphocyte ratio (NLR) offers additional prognostic value 3
  • Leukocytosis with left shift indicates bacterial infection 4

Erythrocyte Sedimentation Rate (ESR)

  • Traditional marker but less specific than CRP or PCT 5, 4
  • Useful for chronic inflammatory conditions and monitoring treatment response

Clinical Decision Algorithm

For suspected bacterial infection/sepsis:

  1. Order PCT as first-line marker (if available) 1
  2. If PCT unavailable, order CRP 1
  3. Add CBC with differential for supporting data 2
  4. Use results with rapid turnaround to guide antimicrobial initiation/discontinuation 1

For differentiating bacterial from viral infection:

  • PCT >0.5 ng/mL suggests bacterial etiology 6
  • PCT remains low in viral infections (except severe influenza/COVID-19) 1
  • CD64 expression on neutrophils can discriminate sepsis from non-infectious inflammation 6

For autoimmune disease flares vs. infection:

  • Elevated PCT indicates bacterial superinfection rather than disease flare 6
  • CRP alone cannot reliably distinguish between the two 6

Critical Pitfalls to Avoid

  • Do not use biomarkers in isolation: Always integrate with clinical assessment 1
  • Do not routinely use biomarkers for established sepsis/septic shock: Guidelines recommend against this due to uncertain benefit and cost issues 1
  • Do not over-interpret persistent elevation in asymptomatic patients: Inflammatory markers may remain elevated without active infection, particularly in elderly patients 7
  • Do not expect PCT to identify specific pathogens: No biomarker predicts the specific infecting agent 6
  • Do not rely on CRP timing for acute decisions: Its 12-24 hour lag makes it less useful for early diagnosis compared to PCT 1

When to Use Baseline Values

Obtain baseline PCT or CRP in fever with lower likelihood of infection to assist with antimicrobial discontinuation decisions 1. This approach reduces unnecessary antimicrobial exposure while maintaining safety.

Related Questions

How should I further evaluate and manage a 27-year-old male with a 7‑week history of fever, sore throat, and dry cough, normal vital signs except borderline hypertension, macrocytosis, mild transaminitis, and slightly elevated inflammatory markers?
In a 50-year-old man presenting with fever, persistent hiccups, mild anemia, neutrophilic leukocytosis, normal platelet count, mildly elevated creatinine, and positive C-reactive protein, what is the most likely diagnosis and appropriate treatment including dosages?
In a female patient with fever, leukocytosis, elevated C‑reactive protein, basal crackles and recent chemotherapy who currently has no dyspnea, should I still administer salbutamol (albuterol) and prednisone?
In a patient with a normal work‑up but persistent elevated C‑reactive protein after 7 days of cefuroxime and azithromycin therapy, what is the appropriate next step?
How should I manage an 85-year-old woman with a known lung mass, persistent marked leukocytosis after recent pneumonia, edema despite furosemide, who is afebrile and refuses further imaging such as PET scan?
What is the appropriate management of peripheral venous phlebitis in pediatric patients?
For localization of pheochromocytoma, is ^18F‑DOPA PET/CT or ^68Ga‑DOTATATE PET/CT the preferred imaging modality?
What are the diagnostic criteria for pre‑eclampsia in a pregnant woman beyond 20 weeks gestation?
Is there any interaction between benzathine penicillin G and lidocaine?
What is the appropriate treatment for pre‑eclampsia?
How does impaired maternal‑infant attachment in a postpartum woman with depression impact the child's long‑term emotional and developmental outcomes, and what specific interventions can a psychiatric‑mental health nurse practitioner (PMHNP) implement to strengthen the bond while treating the mother's depression?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.